ORTEXORTEX News
Tracking VVX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
VV
Earnings PreviewVVX

V2X Outpaces Defense Peers Before Earnings, but Analyst Targets Lag the Rally

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 3 Nov 2026, 04:48

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

V2X, Inc. gained 8.3% in the past week, more than double the median 2.9% advance among its closest defense peers heading into today's earnings report.

Among correlated names, LHX added 7.2% on the week and GD rose 4.6%, while NOC slipped 1.8%. V2X's outperformance is the widest in the group over that window. The stock has now climbed 17.5% over the past month to close at $83.20, which puts it above the mean analyst price target of $88.27, a gap that has narrowed sharply as the shares have run. That compression matters: the Street's most recent target revision went the wrong way, with RBC Capital cutting to $81 from $88 last week while holding a Sector Perform rating, a level now below Friday's close. A prior article noted the stock at $77.17; since then it has added a further $6.

The analyst debate reflects genuine disagreement about where growth comes from next. The bull case rests on a $13.8 billion backlog, bookings coverage of around 3.1 to 3.2 times projected 2025 sales, and improving cash conversion, management reported 23% revenue growth alongside $85.6 million in adjusted EBITDA in the most recent period. The bear case centres on Kuwait: revenue from that market fell roughly 21% to around $93 million in the first quarter of 2026 and now accounts for less than 8% of total sales. Add federal budget timing risk, a net leverage ratio of 2.51 times, and the integration complexity that remains post-merger, and the neutral cluster on the Street, RBC, Morgan Stanley and Citi, has a coherent foundation even if BofA and Citizens hold higher targets of $93 and $102 respectively.

Short positioning is not a dominant feature of this setup. Short interest at 7.6% of the free float is meaningful but has declined about 10% over the past month, and availability is ample at 379%, meaning shares for borrowers remain plentiful at roughly three available for every one currently lent. Cost to borrow is 0.51%, well within normal territory. Options positioning tells a similar story: the put/call ratio at 0.147 is slightly below its 20-day average of 0.156, about 1.5 standard deviations on the call-heavy side, which points toward more interest in upside participation than downside protection ahead of the release.

Institutional ownership adds a layer worth noting. BlackRock increased its stake to 15.8% from 12.3%, a fresh Schedule 13G/A filed October 27. FMR lifted its position to 14.1% from 12.0% in August. An activist holder, AIPCF VI, appears on the 13D register but has reduced its stake to 1.2% from 7.9% since first filing in May 2025; positions on the register are as last disclosed and holders who cross below the 5% threshold may not file again.

The print will test whether V2X's backlog strength and cash generation trajectory justify a share price that has now overshot most of the Street's targets after a month-long rally.

Stocks in this article

See the live data behind this article on ORTEX.

Open VVX on ORTEX →

How this article was generated

Generated
3 Nov 2026, 05:43
Data as of
3 Nov 2026, 04:48
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.